Welcome!
BioNTech
Covid-19
BioNTech beats estimates as vaccine maker pursues more diseases
Last month, BioNTech began an early stage trial for mRNA vaccines against tuberculosis
May 08, 2023
Covid-19
BioNTech sinks as Covid vaccine sales and profit disappoint
Sales fell to 3.2 billion euros, almost 20% short of the average estimate.
August 08, 2022
Covid-19
BioNTech says its Covid vaccine revenue may be lower this year
It is still not clear how many countries will pursue yet another round of shots later in the year.
January 11, 2022
Tech
Top tech trends to watch in 2022
We tend to overestimate the short-term potential of any new technology and, way underestimate its longer-term potential
December 21, 2021
Global Markets
Omicron — it’s Black Friday!
Fortunes have been made in past fire sales. Happy holidays!
November 29, 2021
Covid-19
Updated version of Covid-19 vaccine needed by middle of 2022 as new variants mutate, says BioNTech CEO
"This virus will stay, and the virus will further adapt," says Sahin.
October 03, 2021
Company in the news
BioNTech to open regional HQ and vaccine manufacturing facility in Singapore
The German biotech company plans to make Singapore its regional hub for Southeast Asia.
May 10, 2021
Funds
Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid
A strategic option would be to invest in an exchange traded fund (ETF) with exposure to vaccine-related stocks.
January 15, 2021
Covid-19
Singapore bars travellers from UK amid infection spike, BioNTech claims new vaccines for new variants possible within six weeks
According to Wong, this new strain has not been detected in Singapore yet.
December 22, 2020
Aviation & Engineering
SIA, SIA Engineering, SATS up on vaccine boost, but full recovery still far ahead
As the year draws to a close, all three stocks have clawed back from the bottom.
December 18, 2020